KRDS, a new peptide derived from human lactotransferrin, inhibits platelet aggregation and release reaction.

Abstract

KRDS (Lys-Arg-Asp-Ser), a tetrapeptide from human lactotransferrin, was tested in vitro on human platelet function, and its effects were compared to those of RGDS, a tetrapeptide from human fibrinogen. Both peptides had a high probability of initiating a beta-turn and were highly hydrophilic. KRDS inhibited ADP-induced platelet aggregation [median inhibitory concentration (IC50) 350 microM] and fibrinogen binding (IC50 360 microM) to a lesser extent than RGDS (IC50 75 microM and 20 microM, respectively). Different from RGDS, thrombin-induced serotonin release was inhibited by KRDS (750 microM) on normal platelets (55 +/- 10%) and type I Glanzmann's thrombasthenia platelets (43% +/- 1). However, KRDS had no effect on cytoplasmic Ca2+ mobilization, inositol phospholipid metabolism or protein phosphorylation (myosin light chain P20 and P43). In contrast to RGDS, KRDS does not inhibit the binding of monoclonal antibody PAC-1 to activated platelets. KRDS and RGDS inhibited 4 beta-phorbol-12-myristate-13-acetate (PMA)-induced aggregation and fibrinogen binding, while proteins were normally phosphorylated. Thus, the tetrapeptide KRDS is (a) an inhibitor of serotonin release by a mechanism independent of protein phosphorylation and (b) an inhibitor of fibrinogen binding and, hence, aggregation by a mechanism that may not necessarily involve its direct binding to the glycoprotein IIb-IIIa-complex.

Statistics

0200400'97'99'01'03'05'07'09'11'13'15'17
Citations per Year

827 Citations

Semantic Scholar estimates that this publication has 827 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Mazoyer1990KRDSAN, title={KRDS, a new peptide derived from human lactotransferrin, inhibits platelet aggregation and release reaction.}, author={{\'E}lisabeth Mazoyer and Sylviane L{\'e}vy-Toledano and Francine Rendu and L Hermant and He Jun Lu and A M Fiat and Pierre Joll{\`e}s and Jacques P. Caen}, journal={European journal of biochemistry}, year={1990}, volume={194 1}, pages={43-9} }